Article Text

Download PDFPDF

23 Impact of COVID-19 in gynecologic oncology: a nationwide Italian survey
  1. G Bogani1,
  2. G Apolone1,
  3. A Ditto1,
  4. G Scambia2,
  5. P Benedetti Panici3,
  6. R Angioli4,
  7. S Pignata5,
  8. S Greggi5,
  9. P Scollo6,
  10. D Mezzanzanica1,
  11. M Franchi7,
  12. V Di Donato3,
  13. G Valabrega8,
  14. G Ferrandina2,
  15. I Palaia3,
  16. A Bergamini9,
  17. L Bocciolone9,
  18. A Savarese10,
  19. F Ghezzi11,
  20. J Casarin11,
  21. V Trojano12,
  22. V Chinatera13,
  23. G Giorda14,
  24. M Malzoni15,
  25. G Salerno16,
  26. E Sartori17,
  27. A Testa2,
  28. GF Zannoni2,
  29. F Zullo18,
  30. E Vizza19,
  31. G Trojano20,
  32. A Chiantera21 and
  33. F Raspagliesi1
  1. 1Fondazione Irccs Istituto Nazionale Dei Tumori, Italy
  2. 2UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy, Italy
  3. 3Department of Maternal and Child Health and Urological Sciences, ‘Sapienza’ University of Rome, Rome, Italy, Italy
  4. 4Department of Gynecology, University Campus Biomedico, Rome, Italy, Italy
  5. 5Urogynaecological Medical Oncology Unit Istituto Nazionale Tumori – IRCCS – ‘Fondazione G. Pascale’, 80131 Naples, Italy, Italy
  6. 6Department of Gynecology, Cannizzaro Hospital, Catania, Italy, Italy
  7. 7Department of Obstetrics and Gynaecology, AOUI Verona, University of Verona, Verona, Italy, Italy
  8. 8Candiolo Cancer Institute, FPO – IRCCS – Str. Prov.le 142, km. 3,95 – Candiolo (TO) 10060, Italy, Department of Oncology, University of Torino, Italy
  9. 9Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy, Italy
  10. 10Oncologia Medica 1, IRCCS Istituto Nazionale Tumori Regina Elena, 00144 Roma, Italy, Italy
  11. 11Univerity of Insubria, Ospedale di Circolo Fondazione Macchi, Varese, Italy, Italy
  12. 12Department of Obstetrics and Gynaecology, Mater Dei Hospital-Bari, Italy, Italy
  13. 13Department of Gynecologic Oncology, University of Palermo, Palermo, Sicilia, Italy, Italy
  14. 14Gynaecological Oncology Unit, Centro di Riferimento Oncologico (CRO) di Aviano, IRCCS, Via Franco Gallini 2, 33081, Aviano, Italy., Italy
  15. 15Endoscopica Malzoni, Center for Advanced Endoscopic Gynecological Surgery, Avellino, Italy, Italy
  16. 16Department of gynecology, San Camillo-Forlanini Hospital, 00152 Rome, Italy, Italy
  17. 17Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, Italy
  18. 18Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Via Sergio Pansini, 5, 80131, Naples, Italy, Italy
  19. 19Gynecologic Oncology Unit, Department of Experimental Clinical Oncology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy, Italy
  20. 20Department of Obstetrics and Gynecology, University Medical School ‘A. Moro’, Bari, Italy., Italy
  21. 21Italian Society of Gynecology and Obstetrics, Italy


Objective Several attempts are done in order to control COVID-19 and promote a fair allocation of resources during the outbreak. The Italian society of obstetrics and gynecologist (SIGO), and the Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) are promoting research activities in the field of gynecologic oncology on a national basis, even in the era of COVID-19.

Methods The SIGO and MITO group promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of gynecologist oncologists and the implementation of containment measures of COVID-19 diffusion.

Results Overall, 604 participants completed the questionnaire with a response rate of 70%. The results of this survey suggest that gynecologic oncology units had set a proactive approach to COVID-19 outbreak. Triage methods were adopted in order to minimize the in-hospital diffusion of COVID-19. Although 73% of the participants stated that COVID-19 has not significantly modified their everyday practice, 21% declared a decrease in the use of laparoscopy in favor of open (19%) and vaginal (2%) surgery. Interestingly, about 5% of the participants stated that the use of laparoscopic surgery has increased during the COVID-19 outbreak. However, less than 50% of surgeons adopted specific protection against COVID-19. Additionally, responders suggested to delay cancer treatment (10–15%), and to perform less radical surgical procedures (20–25%) during COVID-19 pandemic.

Conclusions International cooperation is of paramount importance, as heavily affected nations can serve as an example to find out ways to safely preserve clinical activity during the COVID-19 outbreak

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.